Asuragen, Inc. Release: MicroRNA Biomarkers in Cyst Fluid May Improve the Management of Pancreatic Cysts

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc. announced today that data from a collaborative study with Johns Hopkins regarding microRNA biomarkers for use on pancreatic cyst fluid specimens was presented at the American Pancreatic Association Annual Meeting being held November 2-5, 2011 in Chicago.

Back to news